In this issue:  Science   |  Abstracts  |  Industry News   |  Policy Subscribe   |   Unsubscribe    TOP STORIES Advanced Cell Technology and Collaborators at The Casey Eye Institute Present Promising Data Supporting Safety and Efficacy of Stem Cell Therapy to Combat Retinal Disease The research shows long-term functional rescue using hESC-derived cells in both the RCS rat and Elov14 mouse, animal models of retinal degeneration and Stargardt. SCIENCE International Stem Cell Collaboration Results in Discovery of Promising New Stem Cell Type Researchers have announced the discovery of a previously unidentified stem cell population from adult human testis. Hundreds of Cell-surface Proteins Can Be Simultaneously Studied with New Technique The results obtained could help to develop more accurate diagnostic tests and more specific therapies in the future. Placentas Could Be an Important Source of Stem Cells to Fight Disease Researchers have found that the placentas contained large numbers of blood-producing stem cells, which they were able to remove and grow in a cell culture. University of Pittsburgh Cancer Institute Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients The phase III study is assessing the safety and efficacy of StemEx(R), an investigational product derived from stem cells, as an alternative treatment to bone marrow transplants for hematological malignancies, including leukemia and lymphoma. Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community. ABSTRACTS Human Embryonic Stem Cells Differentiate into a Homogeneous Population of Natural Killer Cells with Potent in Vivo Antitumor Activity Using bioluminescent imaging, the researchers demonstrate that H9 line hESC-derived NK cells mediate effective clearance of human tumor cells in vivo. (Blood) SOX15 and SOX7 Differentially Regulate the Myogenic Program in P19 Cells In this study, the researchers have identified novel roles for Sox15 and Sox7 as regulators of muscle precursor cell fate in P19 cells. (Stem Cells) Human Embryonic Stem Cell-derived Neuronal Cells Form Spontaneously Active Neuronal Networks in Vitro To study the potential functionality of hESC-derived neurons, the researchers cultured and monitored the development of hESC-derived neuronal networks on microelectrode arrays. (Experimental Neurology) Reprogramming of Human Somatic Cells Using Human and Animal Oocytes This paper compared the reprogramming of human somatic nuclei using oocytes obtained from animal and human sources. (Cloning and Stem Cells) INDUSTRY Connexon Creative Launches Mammary Cell News Mammary Cell News is a weekly e-newsletter that keeps members of the mammary cell community informed by providing the latest news from all areas of the field, including its science, research and business. Subscribe Today Viewed Archived Issues ReNeuron Signs Manufacturing Contract to Provide Stem Cells for Stroke Clinical Trial ReNeuron Group plc recently announced that it has signed a contract with Angel Biotechnology Holdings plc, under which Angel will manufacture clinical-grade ReN001 stem cell lots for ReNeuron's Phase I clinical trial with its ReN001 therapy in disabled stroke patients. ThermoGenesis Nabs NIH Grant for Stem Cell Delivery ThermoGenesis Corp. said recently it has received a grant from the National Institute of Health to study and develop biomaterials that can be used to deploy placental stem cells in bone repair and regenerative medicine applications. Vitro Receives Adult Stem Cell Patent from the United States Patent and Trademark Office Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it has been awarded United States Patent number 7,527,971 entitled, "Generation and Differentiation of Adult Stem Cells." NeoStem Signs Agreement with Shanghai Corporation to Develop a Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces NeoStem, Inc. announced recently it has signed an exclusive 10-year agreement with Enhance BioMedical Holdings Limited to develop a stem cell collection and treatment network. POLICY Despite Odds, Cities Race to Bet on Biotech At a recent global biotech convention in Atlanta, 27 states, including Hawaii and Oklahoma, paid as much as $100,000 each to entice companies on the exhibition floor. All this for a highly risky industry that has turned a profit only one year in the past four decades. Bob Klein to Leave CIRM Chairman Job Bob Klein, the architect of California's $3 billion stem cell research funding program, will not seek a new term as chairman of the agency.  Learn more about Embryonic Stem Cell News:  Archives  |  Events   |  Subscribe   |  Contact Us This email was sent by: Connexon Creative 400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada